1303438-72-3

Upstream product

• 862973-37-3 (4S,6S)-4,6-diethenyl-2-(2-propen-1-yloxy)-1,3,2-dioxaphosphorinane 2-oxide 
• 1018689-67-2 C₂₀H₃₂O₄ 
• 77-76-9 2,2-dimethoxy-propane 
• 862973-35-1 (1S,6S,8S)-8-vinyl-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-ene 1-oxide 
• 1018689-65-0 C₁₉H₂₅O₆P 
• 1018689-66-1 C₁₉H₂₇O₆P 
• 185549-47-7 (3S,5S)-hepta-1,6-diene-3,5-diol 

Downstream Products

• 1303438-68-7 (5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,E)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-dioxan-4-yl)-5-methyl-7-(triethylsilyloxy)dec-4-en-3-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate 
• 1303438-79-0 (5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,E)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-dioxan-4-yl)-7-hydroxy-5-methyldec-4-en-3-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate 
• 1303438-69-8 (5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,E)-7-acetoxy-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-dioxan-4-yl)-5-methyldec-4-en-3-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate 
• 1303438-80-3 (5S,7R,9S,12R,13S,14S)-15-((4R,8R,9S,10S,12R,E)-4-acetoxy-10,12-dihydroxy-6,9-dimethylheptadeca-6,16-dien-8-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate 
• 1303438-61-0 (R)-2-((4S,6R)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-1,3-dioxan-4-yl)propan-1-ol 
• 1303438-73-4 tert-butyl((R)-2-((4S,6R)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-1,3-dioxan-4-yl)propoxy)dimethylsilane 

Relevant academic research and scientific papers

Total synthesis of dolabelide C: A phosphate-mediated approach

The first synthesis of dolabelide C (1), a cytotoxic marine macrolide, is reported utilizing a phosphate tether-mediated approach. Bicyclic phosphates (S,S,SP)-5 and (R,R,RP)-5 serve as the central building blocks for the constructio